BIOTECHNOLOGY: At the heart of gene edits in human embryos

    loading  Checking for direct PDF access through Ovid


The gene-editing technology CRISPR–Cas has been used in human embryos grownin vitroto correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. See Article p.413

    loading  Loading Related Articles